Inventor
Richland Wayne Tester
Inventor
Marlborough, MA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry9%
C07CAcyclic or carbocyclic compounds4%
C12NMicroorganisms or enzymes4%
C12YEnzymes4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
10,828,300Substituted 2,4-diaminopyrimidines as kinase inhibitors202010,596,1722,4-disubstituted pyrimidines useful as kinase inhibitors202010,570,099Salts of an epidermal growth factor receptor kinase inhibitor202010,010,5482,4-disubstituted pyrimidines useful as kinase inhibitors201810,005,738Salts of an epidermal growth factor receptor kinase inhibitor20189,987,276Substituted 2,4-diaminopyrimidines as kinase inhibitors20189,604,936'Besylate salt of a BTK inhibitor'20179,549,927'Heteroaryl compounds and uses thereof'20179,540,335'Salts of an epidermal growth factor receptor kinase inhibitor'20179,415,049'Heteroaryl compounds and uses thereof'20169,409,921'2,4-disubstituted pyrimidines as kinase inhibitors'20169,393,246'4,6-disubstituted pyrimidines as kinase inhibitors'20169,296,737'Substituted 2,4-diaminopyrimidines as kinase inhibitors'20169,296,704'Substituted pyrimidines as protein kinase inhibitors'20169,212,181'Substituted 2,4-diaminopyrimidines as kinase inhibitors'20159,126,950'Heteroaryl compounds and uses thereof'20159,108,927'Salts of an epidermal growth factor receptor kinase inhibitor'20159,040,541'4,6-disubstituted pyrimidines useful as kinase inhibitors'20158,748,606'4,6-diaminopyrimidines useful as kinase inhibitors'20148,710,222'2,4-disubstituted pyrimidines useful as kinase inhibitors'20148,609,679'2,4-diaminopyrimidines useful as kinase inhibitors'20138,563,568'Besylate salt of a BTK inhibitor'20138,450,335'2,4-disubstituted pyrimidines useful as kinase inhibitors'20138,445,498'4,6-disubstituted pyrimidines useful as kinase inhibitors'20138,338,439'2,4-disubstituted pyrimidines useful as kinase inhibitors'20128,329,901'4,6-disubstitued pyrimidines useful as kinase inhibitors'20127,989,465'4,6-disubstituted pyrimidines useful as kinase inhibitors'20117,982,036'4,6-disubstitued pyrimidines useful as kinase inhibitors'20117,220,763'Indole-type derivatives as inhibitors of p38 kinase'20076,890,938'Indole-type inhibitors of p38 kinase'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005Based in San Jose, CA, US· patent location history
2007Based in Alameda, CA, US· patent location history
2011–2020Based in Marlborough, MA, US· patent location history
2012–2017Patents assigned to CELGENE AVILOMICS RES INC (20)· patent assignee history
2012–2013Patents assigned to KLUGE ARTHUR F (4)· patent assignee history
2012–2013Patents assigned to SINGH JUSWINDER (4)· patent assignee history
2012–2013Patents assigned to TESTER RICHLAND WAYNE (3)· patent assignee history
2017–2020Patents assigned to CELGENE CAR LLC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE AVILOMICS RES INC | 20 | 2012–2017 |
| CELGENE CAR LLC | 7 | 2017–2020 |
| KLUGE ARTHUR F | 4 | 2012–2013 |
| SINGH JUSWINDER | 4 | 2012–2013 |
| TESTER RICHLAND WAYNEself | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Marlborough, Massachusetts, US | 28 | 2011–2020 |
| Alameda, California, US | 1 | 2007 |
| San Jose, California, US | 1 | 2005 |